BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2025 10:47:37 AM | Browse: 199 | Download: 796
 |
Received |
|
2024-10-31 17:42 |
|
Peer-Review Started |
|
2024-11-05 01:36 |
|
First Decision by Editorial Office Director |
|
2024-12-11 08:45 |
|
Return for Revision |
|
2024-12-11 08:45 |
|
Revised |
|
2024-12-24 08:12 |
|
Publication Fee Transferred |
|
2024-12-30 01:21 |
|
Second Decision by Editor |
|
2025-02-05 11:45 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-02-12 08:35 |
|
Articles in Press |
|
2025-02-12 08:35 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-02-20 08:25 |
|
Publish the Manuscript Online |
|
2025-02-28 10:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Prospective Study |
| Article Title |
Clinical utility of glycated albumin and 1,5-anhydroglucitol in the screening and prediction of diabetes: A multi-center study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kam-Ching Ku, Junda Zhong, Erfei Song, Carol Ho-Yi Fong, Karen Siu-Ling Lam, Aimin Xu, Chi-Ho Lee and Chloe Yu-Yan Cheung |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Hong Kong Research Grants Council Area of Excellence |
AoE/M/707-18 |
|
| Corresponding Author |
Chloe Yu-Yan Cheung, PhD, Department of Medicine, University of Hong Kong, No. 21 Sassoon Road, Pokfulam, Hong Kong 999077, China. cyy0219@hku.hk |
| Key Words |
Diabetes; Biomarkers; Prediction; Glycated albumin; 1,5-anhydroglucitol |
| Core Tip |
This study provides supporting evidence on the effectiveness of glycated albumin (GA) in identifying diabetes and monitoring glycemic control among morbidly-obese individuals. It also highlights the potential clinical utility of the simple ‘B3A’ model, which comprises body mass index, glycated hemoglobin, GA and 1,5-anhydroglucitol (1,5-AG), for predicting diabetes in a community-based cohort. Our findings suggest that both GA and 1,5-AG could serve as supplementary biomarkers, potentially replacing the conventional clinical indicators to predict diabetes. The ‘B3A’ model requires only a single tube of blood sample and simple non-invasive body measurements, making it especially useful for large-scale population screening. |
| Publish Date |
2025-02-28 10:47 |
| Citation |
Ku KC, Zhong J, Song E, Fong CHY, Lam KSL, Xu A, Lee CH, Cheung CYY. Clinical utility of glycated albumin and 1,5-anhydroglucitol in the screening and prediction of diabetes: A multi-center study. World J Diabetes 2025; 16(4): 102867 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i4/102867.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i4.102867 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
